167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease
167. 一项评估 Clesrovimab 在患严重呼吸道合胞病毒 (RSV) 疾病风险增加的婴幼儿中的安全性、有效性和药代动力学 (PK) 的 3 期随机对照试验
期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics13111941
Ganchi, Feroz Abubaker; Hardcastle, Timothy Craig; Zar, Heather J; Bont, Louis J; Manzoni, Paolo; Munoz, Flor M; Ramilo, Octavio; Chen, Po-Yen; Novoa Pizarro, Jose M; Ordonez, Gustavo A; Tsolia, Maria; Tapiero, Bruce; Acuña, Mirta; Castellanos, Javier M; Meyer, Michael; Morioka, Ichiro; Chen, Ziqiang; Railkar, Radha A; Zang, Xiaowei; Krick, Andrea L; Lee, Andrew W; Castagnini, Luis A; Sinha, Anushua
